date:Apr 24, 2013
businesses Rhone will acquire had aggregate sales of about $3,317 million in 2012.
Mr. Hoetmer said the continuing bio-based business has had a challenging start to the year.
We saw no significant changes in overall market conditions in the first quarter, and sales was impacted by a lower number of trading days compared to Q1 last year, he said. Improving on the trend of previous quarters Purac volumes on balance were stable, driven by growth in the chemicals and pharma segment, with the food